5-34007995-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_014324.6(AMACR):c.25G>A(p.Val9Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.482 in 1,610,698 control chromosomes in the GnomAD database, including 198,943 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.41 ( 14732 hom., cov: 32)
Exomes 𝑓: 0.49 ( 184211 hom. )
Consequence
AMACR
NM_014324.6 missense
NM_014324.6 missense
Scores
1
4
13
Clinical Significance
Conservation
PhyloP100: -0.850
Genes affected
AMACR (HGNC:451): (alpha-methylacyl-CoA racemase) This gene encodes a racemase. The encoded enzyme interconverts pristanoyl-CoA and C27-bile acylCoAs between their (R)- and (S)-stereoisomers. The conversion to the (S)-stereoisomers is necessary for degradation of these substrates by peroxisomal beta-oxidation. Encoded proteins from this locus localize to both mitochondria and peroxisomes. Mutations in this gene may be associated with adult-onset sensorimotor neuropathy, pigmentary retinopathy, and adrenomyeloneuropathy due to defects in bile acid synthesis. Alternatively spliced transcript variants have been described. Read-through transcription also exists between this gene and the upstream neighboring C1QTNF3 (C1q and tumor necrosis factor related protein 3) gene. [provided by RefSeq, Mar 2011]
C1QTNF3-AMACR (HGNC:49198): (C1QTNF3-AMACR readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring C1q and tumor necrosis factor related protein 3 (C1QTNF3) and alpha-methylacyl-CoA racemase (AMACR) genes on chromosome 5. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is thus not likely to produce a protein product. [provided by RefSeq, Mar 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=7.387839E-5).
BP6
Variant 5-34007995-C-T is Benign according to our data. Variant chr5-34007995-C-T is described in ClinVar as [Benign]. Clinvar id is 128356.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-34007995-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.526 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AMACR | NM_014324.6 | c.25G>A | p.Val9Met | missense_variant | 1/5 | ENST00000335606.11 | NP_055139.4 | |
AMACR | NM_001167595.2 | c.25G>A | p.Val9Met | missense_variant | 1/6 | NP_001161067.1 | ||
AMACR | NM_203382.3 | c.25G>A | p.Val9Met | missense_variant | 1/4 | NP_976316.1 | ||
C1QTNF3-AMACR | NR_037951.1 | n.765-2096G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AMACR | ENST00000335606.11 | c.25G>A | p.Val9Met | missense_variant | 1/5 | 1 | NM_014324.6 | ENSP00000334424.6 | ||
ENSG00000289791 | ENST00000382068.3 | c.25G>A | p.Val9Met | missense_variant | 1/4 | 1 | ENSP00000477108.1 | |||
C1QTNF3-AMACR | ENST00000382079.3 | n.690-2096G>A | intron_variant | 2 | ENSP00000371511.3 |
Frequencies
GnomAD3 genomes AF: 0.412 AC: 62593AN: 151940Hom.: 14732 Cov.: 32
GnomAD3 genomes
AF:
AC:
62593
AN:
151940
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.424 AC: 100169AN: 236178Hom.: 23930 AF XY: 0.416 AC XY: 53860AN XY: 129622
GnomAD3 exomes
AF:
AC:
100169
AN:
236178
Hom.:
AF XY:
AC XY:
53860
AN XY:
129622
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.490 AC: 714023AN: 1458640Hom.: 184211 Cov.: 72 AF XY: 0.480 AC XY: 348012AN XY: 725690
GnomAD4 exome
AF:
AC:
714023
AN:
1458640
Hom.:
Cov.:
72
AF XY:
AC XY:
348012
AN XY:
725690
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.412 AC: 62597AN: 152058Hom.: 14732 Cov.: 32 AF XY: 0.408 AC XY: 30309AN XY: 74320
GnomAD4 genome
AF:
AC:
62597
AN:
152058
Hom.:
Cov.:
32
AF XY:
AC XY:
30309
AN XY:
74320
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
2004
ALSPAC
AF:
AC:
2063
ESP6500AA
AF:
AC:
920
ESP6500EA
AF:
AC:
4492
ExAC
AF:
AC:
50167
Asia WGS
AF:
AC:
772
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 06, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jul 18, 2017 | - - |
Likely benign, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | - | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. - |
Alpha-methylacyl-CoA racemase deficiency Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Mar 06, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 14, 2021 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, no assertion criteria provided | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Oct 22, 2015 | - - |
Congenital bile acid synthesis defect 4 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 14, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.;.;.;T;T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T;T;T;T;T;T
MetaRNN
Benign
T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M;M;M;.;.;.;.
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N;N;.;.;.
REVEL
Benign
Sift
Benign
D;T;D;D;.;.;.
Sift4G
Uncertain
D;D;D;D;D;D;D
Polyphen
B;P;.;B;.;.;.
Vest4
MPC
0.94
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at